Related Experiment Video
Updated: Mar 16, 2026

A Novel in vivo Gene Transfer Technique and in vitro Cell Based Assays for the Study of Bone Loss in Musculoskeletal Disorders
Published on: June 8, 2014
Dicer ablation in osteoblasts by Runx2 driven cre-loxP recombination affects bone integrity, but not
Peng Liu1,2, Mario Baumgart2, Marco Groth2
1Institute of Comparative Molecular Endocrinology (CME), Ulm University, Ulm, Germany.
Abstract:
Glucocorticoid-induced osteoporosis (GIO) is one of the major side effects of long-term glucocorticoid (GC) therapy mediated mainly via the suppression of bone formation and osteoblast differentiation independently of GC receptor (GR) dimerization. Since microRNAs play a critical role in osteoblast differentiation processes, we investigated the role of Dicer dependent microRNAs in the GC-induced suppression of osteoblast differentiation. MicroRNA sequencing of dexamethasone-treated wild-type and GR dimer-deficient mesenchymal stromal cells revealed GC-controlled miRNA expression in a GR dimer-dependent and GR dimer-independent manner. To determine the functional relevance of mature miRNAs in GC-induced osteoblast suppression, mice with an osteoblast-specific deletion of Dicer (Dicer(Runx2Cre)) were exposed to glucocorticoids. In vitro generated Dicer-deficient osteoblasts were treated with dexamethasone and analyzed for proliferation, differentiation and mineralization capacity. In vivo, abrogation of Dicer-dependent miRNA biogenesis in osteoblasts led to growth retardation and impaired bone formation. However, subjecting these mice to GIO showed that bone formation was similar reduced in Dicer(Runx2Cre) mice and littermate control mice upon GC treatment. In line, differentiation of Dicer deficient osteoblasts was suppressed to the same extent as wild type cells by GC treatment. Therefore, Dicer-dependent small RNA biogenesis in osteoblasts plays only a minor role in the pathogenesis of GC-induced inhibition of bone formation.
Insights
Glucocorticoid-induced osteoporosis (GIO) involves microRNAs. Dicer-dependent microRNAs in bone cells play a minor role in GIO, as their absence did not alter the negative effects of glucocorticoids on bone formation.
Area of Science:
- Molecular Biology
- Endocrinology
- Bone Biology
Background:
- Glucocorticoid-induced osteoporosis (GIO) is a significant adverse effect of long-term glucocorticoid (GC) treatment.
- GIO primarily occurs through suppressed bone formation and osteoblast differentiation, independent of GC receptor (GR) dimerization.
- MicroRNAs are crucial regulators of osteoblast differentiation.
Purpose of the Study:
- To investigate the role of Dicer-dependent microRNAs in GC-induced suppression of osteoblast differentiation.
- To elucidate the GR dimer-dependent and -independent microRNA expression patterns under GC treatment.
- To determine the functional significance of microRNAs in GIO pathogenesis.
Main Methods:
- MicroRNA sequencing on dexamethasone-treated wild-type and GR dimer-deficient mesenchymal stromal cells.
- Generation of mice with osteoblast-specific deletion of Dicer (Dicer(Runx2Cre)).
- In vitro analysis of Dicer-deficient osteoblasts (proliferation, differentiation, mineralization) and in vivo GIO models.
Main Results:
- GC treatment altered miRNA expression in a GR dimer-dependent and -independent manner.
- Osteoblast-specific Dicer deletion resulted in growth retardation and impaired bone formation.
- However, GIO induction showed similar bone formation reduction in Dicer(Runx2Cre) mice and controls.
- GC treatment suppressed differentiation of Dicer-deficient osteoblasts to the same extent as wild-type cells.
Conclusions:
- Dicer-dependent small RNA biogenesis in osteoblasts plays a minor role in the pathogenesis of GC-induced bone formation inhibition.
- GC-induced suppression of osteoblast differentiation is largely independent of Dicer-dependent microRNAs.
Related Concept Videos
Osteoclasts in Bone Remodeling
Bone Remodeling
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone Formation by Endochondral Ossification
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Bone Formation by Intramembranous Ossification
The process begins when mesenchymal cells in the embryonic skeleton gather together and differentiate into osteogenic cells, which then develop into ...

